Pulmonx Corp Stock Analysis

Pulmonx Stock Analysis Notes

About 93.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.34. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pulmonx Corp recorded a loss per share of 1.44. The entity had not issued any dividends in recent years. Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. Pulmonx Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 253 people. To find out more about Pulmonx Corp contact Steven Williamson at 650 364 0400 or learn more at https://pulmonx.com.

Pulmonx Corp Investment Alerts

Pulmonx Corp Upcoming and Recent Events

Pulmonx Largest EPS Surprises

View All Earnings Estimates

Pulmonx Stock Institutional Investors

Note, although Pulmonx Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pulmonx Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 104.27 M.

Pulmonx Profitablity

The company has Profit Margin (PM) of (0.65) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.

Management Efficiency

Pulmonx Corp has return on total asset (ROA) of (0.2221) % which means that it has lost $0.2221 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6068) %, meaning that it created substantial loss on money invested by shareholders. Pulmonx Corp's management efficiency ratios could be used to measure how well Pulmonx Corp manages its routine affairs as well as how well it operates its assets and liabilities. The Pulmonx Corp's current Net Tangible Assets is estimated to increase to about 183.1 M, while Total Assets are projected to decrease to roughly 101.3 M.

Technical Drivers

As of the 1st of July, Pulmonx Corp holds the Coefficient Of Variation of (402.40), risk adjusted performance of (0.40), and Variance of 27.26. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmonx Corp, as well as the relationship between them. Please check Pulmonx Corp variance and potential upside to decide if Pulmonx Corp is priced some-what accurately, providing market reflects its current price of 2.69 per share. Please also confirm Pulmonx Corp jensen alpha, which is currently at (1.35) to check out the company can sustain itself at a future point.

Pulmonx Corp Price Movement Analysis

Pulmonx Corp Insider Trading Activities

Pulmonx Corp Outstanding Bonds

Pulmonx Corp Predictive Daily Indicators

Pulmonx Corp Forecast Models

Pulmonx Corp's time-series forecasting models are one of many Pulmonx Corp's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pulmonx Corp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pulmonx Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pulmonx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pulmonx Corp. By using and applying Pulmonx Stock analysis, traders can create a robust methodology for identifying Pulmonx entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pulmonx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pulmonx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pulmonx Corp stock analysis indicators help investors evaluate how Pulmonx Corp stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pulmonx Corp shares will generate the highest return on investment. By understating and applying Pulmonx Corp stock analysis, traders can identify Pulmonx Corp position entry and exit signals to maximize returns.

When running Pulmonx Corp's price analysis, check to measure Pulmonx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pulmonx Corp is operating at the current time. Most of Pulmonx Corp's value examination focuses on studying past and present price action to predict the probability of Pulmonx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pulmonx Corp's price. Additionally, you may evaluate how the addition of Pulmonx Corp to your portfolios can decrease your overall portfolio volatility.